IP Library Granted Patent US 8,859,802
Granted Patent B2
US 8,859,802 · App. 13/006,350 · Granted Oct 14, 2014

Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides

Inventors: Zhenwei Miao (San Diego, CA); Junjie Liu (San Diego, CA); Thea Norman (San Diego, CA); Russell Driver (Madison, WI)
Assignee: Ambrx, Inc.
C07C229/36C07D317/22C07D307/83C07D209/38G01N33/5008C07C237/32C07C251/54C07D317/28A61K31/198G01N2500/00C07D317/26C07D333/72C07C251/28C07D307/89G01N33/68A61K38/17C07D317/30C07C2101/08C07C251/86C07C251/60C12P21/02C07C323/63C07D307/88G01N33/6848
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,859,802
App. No.
13/006,350
Granted
Oct 14, 2014
Kind
B2
Abstract

Disclosed herein are compounds useful in the preparation of non-natural amino acids and polypeptides that include at least one non-natural amino acid, and methods for making such non-natural amino acids and polypeptides. The non-natural amino acids, by themselves or as a part of a polypeptide, can include a wide range of possible functionalities, but typical have at least one oxime, carbonyl, dicarbonyl, and/or hydroxylamine group. Also disclosed herein are compounds useful in the preparation of non-natural amino acid polypeptides that are further modified post-translationally, methods for effecting such modifications, and methods for purifying such resultant polypeptides. Typically, the modified non-natural amino acid polypeptides include at least one oxime, carbonyl, dicarbonyl, and/or hydroxylamine group. Further disclosed are methods for using such non-natural amino acid polypeptides and modified non-natural amino acid polypeptides, including therapeutic, diagnostic, and other biotechnology uses.

Claims (11)

1. A compound having the structure selected from:

wherein:

X is a polymer;

L is -(alkylene or substituted alkylene)-N(R′)C(O)O-(alkylene or substituted alkylene)-; and

each R′ is independently H, alkyl, or substituted alkyl.

2. The compound of claim 1 wherein the polymer is a water-soluble polymer.

3. The compound of claim 2 wherein the water-soluble polymer is polyalkylene glycol.

4. The compound of claim 3 wherein the polyalkylene glycol is a polyethylene glycol or a derivative of polyethylene glycol.

5. The compound of claim 4 wherein the polyethylene glycol has a molecular weight selected from the group consisting of about 35,000 Da, about 30,000 Da, about 25,000 Da, about 20,000 Da, about 15,000 Da, about 10,000 Da, about 9,000 Da, about 8,000 Da, about 7,000 Da, about 6,000 Da, about 5,000 Da.

6. The compound of claim 4 wherein the polyethylene glycol has a molecular weight of about 5000 Da to about 30,000 Da.

7. The compound of claim 1 selected from:

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 21, 2011
From: MIAO, ZHENWEI; LIU, JUNJIE; NORMAN, THEA; DRIVER, RUSSELL
To: AMBRX, INC.
Reel/Frame 025679/0874 →
Continuity (9)
Division 11873347 · Oct 16, 2007
Continuation 11313306 · Dec 21, 2005
Provisional Application 60638418 · Dec 22, 2004
Provisional Application 60638527 · Dec 22, 2004
Provisional Application 60639195 · Dec 22, 2004
Provisional Application 60696210 · Jul 1, 2005
Provisional Application 60696302 · Jul 1, 2005
Provisional Application 60696068 · Jul 1, 2005
Related Publication 20110118501A1 · May 19, 2011